Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosa
about
Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung InfectionsExperimental evolution in biofilm populations.The fitness costs of antibiotic resistance mutationsCan the experimental evolution programme help us elucidate the genetic basis of adaptation in nature?Endogenous stress caused by faulty oxidation reactions fosters evolution of 2,4-dinitrotoluene-degrading bacteriaConvergent evolution of marine mammals is associated with distinct substitutions in common genesGenomics of antibiotic-resistance prediction in Pseudomonas aeruginosa.Within-Host Evolution of Burkholderia pseudomallei during Chronic Infection of Seven Australasian Cystic Fibrosis Patients.Causes of molecular convergence and parallelism in protein evolution.Effective use of a horizontally-transferred pathway for dichloromethane catabolism requires post-transfer refinement.Sub-inhibitory concentrations of some antibiotics can drive diversification of Pseudomonas aeruginosa populations in artificial sputum mediumToo much of a good thing: the unique and repeated paths toward copper adaptation.Pseudomonas aeruginosa enhances production of a non-alginate exopolysaccharide during long-term colonization of the cystic fibrosis lung.Antagonistic Coevolution Drives Whack-a-Mole Sensitivity in Gene Regulatory NetworksThe properties of spontaneous mutations in the opportunistic pathogen Pseudomonas aeruginosaPseudomonas aeruginosa AmpR: an acute-chronic switch regulator.Real-Time Monitoring of nfxB Mutant Occurrence and Dynamics in Pseudomonas aeruginosa Biofilm Exposed to Subinhibitory Concentrations of CiprofloxacinTemperate phages both mediate and drive adaptive evolution in pathogen biofilms.Reactive oxygen species drive evolution of pro-biofilm variants in pathogens by modulating cyclic-di-GMP levels.Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence.A temporal examination of the planktonic and biofilm proteome of whole cell Pseudomonas aeruginosa PAO1 using quantitative mass spectrometry.Experimental evolution of pathogenesis: "patient" research.Whole genome sequencing of bacteria in cystic fibrosis as a model for bacterial genome adaptation and evolution.Evolutionary insight from whole-genome sequencing of Pseudomonas aeruginosa from cystic fibrosis patients.Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus.What drives parallel evolution?: How population size and mutational variation contribute to repeated evolution.Evolved resistance to colistin and its loss due to genetic reversion in Pseudomonas aeruginosa.The fitness effect of mutations across environments: Fisher's geometrical model with multiple optima.Evolution of Cost-Free Resistance under Fluctuating Drug Selection in Pseudomonas aeruginosa.Emergence of polymyxin B resistance influences pathogenicity in Pseudomonas aeruginosa mutatorsMolecular identification and genotyping of Pseudomonas aeruginosa isolated from cystic fibrosis and non-cystic fibrosis patients with bronchiectasis.Testing the role of genetic background in parallel evolution using the comparative experimental evolution of antibiotic resistance.Host immune responses accelerate pathogen evolution.Dynamics of Mutations during Development of Resistance by Pseudomonas aeruginosa against Five Antibiotics.Sublethal ciprofloxacin treatment leads to rapid development of high-level ciprofloxacin resistance during long-term experimental evolution of Pseudomonas aeruginosaCharacterization of mutations in the PAS domain of the EvgS sensor kinase selected by laboratory evolution for acid resistance in Escherichia coli.Comparative genomics and transcriptomics analysis of experimentally evolved Escherichia coli MC1000 in complex environments.Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in Pseudomonas aeruginosa.Using long-term experimental evolution to uncover the patterns and determinants of molecular evolution of an Escherichia coli natural isolate in the streptomycin-treated mouse gut.Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic Infections.
P2860
Q26768034-C75367B0-C52E-49CE-B279-80E5256D50FAQ26768691-48ABC7C6-83B9-4FA4-9A88-B06676AF746DQ26825334-52FD6B4E-C3D5-419F-A394-8A35F7E0AB33Q28082810-E89035F5-0D5E-4C82-9286-0CC7345CF2EEQ28536141-7B071E06-03AA-4FC0-9242-620A681D7F1AQ28607668-F53B162D-64E5-4F6C-8758-5AD01EF95153Q30234118-064749B9-3521-4B6F-8369-C0D4912FE095Q33555304-683A3055-8F34-4AB1-8B48-8AE8061C994CQ33829798-C8D8B664-6370-4F1C-873E-CEBFF33D1A8CQ34737585-4F06A04E-EED4-4FF4-99C3-E11FAA76F96DQ34860393-00EA6402-9BA0-4CA8-A43C-601B0A35F82DQ35050923-F59DF5D2-F641-43AA-8AF8-86762E7568AAQ35064250-A79CB3A1-7C63-431C-AF33-E27A58CB30DBQ35801509-1554DA86-45E8-4B66-A48C-D426BDD7B706Q35885995-87400658-4C32-4C19-BB54-60CF8FE4AACDQ35975439-8A0E3F33-8B44-4BBD-8351-92FE3D69A715Q36228925-104FC641-1AC7-436F-B36B-8A47DF88CC54Q37126836-3E5C8BBA-909C-47BC-A5D9-C00A1A060DB3Q37464130-3E185778-D5BB-4697-A628-6AF7856E204AQ37643058-40C4C493-5EA3-4A7A-8CE4-77C92679B050Q37687425-9C0B9C23-B7B8-423B-B7EA-114F07440759Q38112110-254BF32E-43A5-4B80-B2CF-32266E41ED1EQ38185756-980824B4-1F09-4679-B0BA-CF9FFC5D4941Q38417030-A2A629D4-8385-467A-8836-BABFFA1EEFF1Q38868528-F8CC69B5-C76D-44FE-AE0A-5911B5785CDEQ40446556-4C4AA15C-5AAD-40A4-BF31-205B4410A136Q40685676-E11B9C37-9964-4A50-98AB-C9DF24B900EFQ41020117-97208E95-58ED-433A-874D-C08E14DAC4C8Q41066625-DC71E52C-D70D-4001-A8D9-47B152E556AEQ41280370-595150CA-06B6-48EA-BACF-1E265FCBEE26Q41461270-A3B8C449-2118-4390-B69D-5ACE62A48B58Q41846993-F6A61990-DD02-4CF0-B617-C3D3D8688D37Q41968421-51B135AE-D14E-46C1-905C-F68987393B77Q42089533-68F006C7-8DCC-4F7B-879D-F50121C93FDCQ42572942-14A2702D-58BA-40D5-8A83-2F9545DB2605Q43065961-1800A338-8F68-4E10-A4CB-2785A6C01ABDQ44030517-B343DBD6-7290-4C2F-8D83-E46F1E79CEFBQ45897898-98A83D94-FA14-4908-83FA-F0E2D0682DB9Q47165136-40C66865-9992-4BAC-AF96-0E58FC5A9046Q47200948-128298A7-57A7-430F-A31E-09C27F8E5C40
P2860
Genomics of adaptation during experimental evolution of the opportunistic pathogen Pseudomonas aeruginosa
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Genomics of adaptation during ...... athogen Pseudomonas aeruginosa
@ast
Genomics of adaptation during ...... athogen Pseudomonas aeruginosa
@en
Genomics of adaptation during ...... athogen Pseudomonas aeruginosa
@en-gb
Genomics of adaptation during ...... athogen Pseudomonas aeruginosa
@nl
type
label
Genomics of adaptation during ...... athogen Pseudomonas aeruginosa
@ast
Genomics of adaptation during ...... athogen Pseudomonas aeruginosa
@en
Genomics of adaptation during ...... athogen Pseudomonas aeruginosa
@en-gb
Genomics of adaptation during ...... athogen Pseudomonas aeruginosa
@nl
prefLabel
Genomics of adaptation during ...... athogen Pseudomonas aeruginosa
@ast
Genomics of adaptation during ...... athogen Pseudomonas aeruginosa
@en
Genomics of adaptation during ...... athogen Pseudomonas aeruginosa
@en-gb
Genomics of adaptation during ...... athogen Pseudomonas aeruginosa
@nl
P2860
P3181
P1433
P1476
Genomics of adaptation during ...... athogen Pseudomonas aeruginosa
@en
P2093
Nicolas Rodrigue
P2860
P304
P3181
P356
10.1371/JOURNAL.PGEN.1002928
P407
P50
P577
2012-09-01T00:00:00Z